Abstract
The alarming increase of antimicrobial resistance has led to a growing number of studies aiming to develop novel antimicrobial therapeutics. Natural antimicrobial peptides possess a potent and broad-spectrum antimicrobial activity combined with diverse and unique structural motifs, which confer their different mechanisms of action. These peptides are ubiquitous in organisms and are integral to the innate immune system. Recently, identification of antimicrobial peptides from marine crustaceans has become the centre of attention of many researchers. This increasing interest stems from the remarkable diversity in the structural and genetic composition of these peptides compared to terrestrial counterparts. Thus, peptides from marine crustaceans can serve as future templates for novel antimicrobial agents. Here, we provide an overview of various antimicrobial peptides from the marine crustaceans, their antimicrobial activity and structure- activity relationships. We also discuss the potential and challenges of their development as new antimicrobial agents.
Keywords: Antimicrobial activity, structure-activity relationship, antimicrobial peptides, mechanism of action, marine peptides, crustaceans.
Current Medicinal Chemistry
Title:Antimicrobial Peptides of Marine Crustaceans: The Potential and Challenges of Developing Therapeutic Agents
Volume: 25 Issue: 19
Author(s): Negar T. Zanjani, Monica Miranda-Saksena, Anthony L. Cunningham*Fariba Dehghani*
Affiliation:
- Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW,Australia
- The University of Sydney, School of Chemical and Biomolecular Engineering, Sydney, NSW,Australia
Keywords: Antimicrobial activity, structure-activity relationship, antimicrobial peptides, mechanism of action, marine peptides, crustaceans.
Abstract: The alarming increase of antimicrobial resistance has led to a growing number of studies aiming to develop novel antimicrobial therapeutics. Natural antimicrobial peptides possess a potent and broad-spectrum antimicrobial activity combined with diverse and unique structural motifs, which confer their different mechanisms of action. These peptides are ubiquitous in organisms and are integral to the innate immune system. Recently, identification of antimicrobial peptides from marine crustaceans has become the centre of attention of many researchers. This increasing interest stems from the remarkable diversity in the structural and genetic composition of these peptides compared to terrestrial counterparts. Thus, peptides from marine crustaceans can serve as future templates for novel antimicrobial agents. Here, we provide an overview of various antimicrobial peptides from the marine crustaceans, their antimicrobial activity and structure- activity relationships. We also discuss the potential and challenges of their development as new antimicrobial agents.
Export Options
About this article
Cite this article as:
Zanjani T. Negar , Miranda-Saksena Monica, Cunningham L. Anthony*, Dehghani Fariba*, Antimicrobial Peptides of Marine Crustaceans: The Potential and Challenges of Developing Therapeutic Agents, Current Medicinal Chemistry 2018; 25 (19) . https://dx.doi.org/10.2174/0929867324666171106155936
DOI https://dx.doi.org/10.2174/0929867324666171106155936 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ImmunemiR - A Database of Prioritized Immune miRNA Disease Associations and its Interactome
MicroRNA Serum Microbial- and Host-Derived Markers of Periodontal Diseases: A Review
Current Medicinal Chemistry Cytokines Play a Key Role in Communication between Mesenchymal Stem Cells and Brain Cancer Cells
Protein & Peptide Letters SIRT1 – An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis
Current Vascular Pharmacology Block Copolymers for Drug Delivery Nano Systems (DDnSs)
Current Medicinal Chemistry Editorial: Recent Advances of Cell and Gene Therapy in Kidney Diseases
Current Gene Therapy Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Mitochondrial and Plastid Functions as Antimalarial Drug Targets
Current Drug Targets - Infectious Disorders Cytokine Gene Polymorphisms in Cancer and Inflammatory Disorders
Current Immunology Reviews (Discontinued) Clinical Trials in Relapsing-Remitting Multiple Sclerosis /A New Proposal for Dealing with Basic Problems and Restrictions/
Reviews on Recent Clinical Trials Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
Current Topics in Medicinal Chemistry 3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine
Drug Delivery Letters Using Insights into Pim1 Structure to Design New Anticancer Drugs
Current Pharmaceutical Design Development of New Immunotherapies for Japanese Cedar Pollinosis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System
CNS & Neurological Disorders - Drug Targets Stem Cells and Combinatorial Science
Combinatorial Chemistry & High Throughput Screening C-Met Inhibitors are Potential Novel Therapeutic Agents Against Listeria monocytogenes Infection Through Blocking the Bacteria Entry into Nonphagocytic Cells
Current Topics in Medicinal Chemistry Making Sense of Molecular Signatures in The Immune System
Combinatorial Chemistry & High Throughput Screening Cellular Antiviral Factors that Target Particle Infectivity of HIV-1
Current HIV Research